Application Information

This drug has been submitted to the FDA under the reference 021268/001.

Names and composition

"TEVETEN HCT" is the commercial name of a drug composed of EPROSARTAN MESYLATE and HYDROCHLOROTHIAZIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021268/001 TEVETEN HCT EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE TABLET/ORAL 600MG and 12.5MG
021268/002 TEVETEN HCT EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE TABLET/ORAL 600MG and 25MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021268/001 TEVETEN HCT EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE TABLET/ORAL 600MG and 12.5MG
021268/002 TEVETEN HCT EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE TABLET/ORAL 600MG and 25MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved